Huadong Medicine's (SHE:000963) UK-based aesthetic subsidiary Sinclair Pharmaceuticals has received approval from China's National Medical Products Administration for its undereye filler, MaiLiPrecise.
MaiLiPrecise is the first injectable product in China for treating infraorbital, or undereye, retraction, according to a Shenzhen bourse filing on Wednesday.
The product is part of the MaiLi line of dermal fillers produced by Sinclair. It originated from Kylane Laboratoires, a Swiss professional medical aesthetics R&D company in which Sinclair holds a stake, Huadong said.